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Guanylate cyclase-activating protein (GCAP) is a 
novel Ca:*-binding protein that stim ulates synthesis of 
cGMP in photoreceptors. Molecular cloning o f human 
and mouse GCAP cDNA revealed that the known mam­
malian GCAPs are more than 90% similar, consist o f  201­
205 am ino acids, and contain three identically con­
served EF hand Ca2+ binding sites. The sequence  
hom ology with recoverin, a related photoreceptor Ca2+- 
binding protein, is less than 35%. In situ hybridization in 
primate retinas shows that the GCAP gene is expressed  
exclusively in  photoreceptor inner segments. To inves­
tigate the GCAP gene structure, we probed 10 eucaryotic  
genomic DNAs with a bovine GCAP cDNA under strin­
gent conditions. The results dem onstrate that the GCAP 
gene has been w ell conserved during evolution o f verte­
brate species and that each gene is most likely present 
as a single copy. By genomic cloning, polym erase chain  
reaction, mapping, and direct sequencing, we show that 
the human GCAP gene spans approximately 6 kilobases 
of genomic DNA, and consists o f four exons (>250, 146, 
94, and 800 base pairs) separated by three introns {4,5 
kilobases, 370 base pairs, and 347 base pairs). Using 
human/hamster hybrid panels and fluorescent in situ 
hybridization, the GCAP gene was localized to the short 
arm o f chromosome 6 (p21.1).
Light-detecting rod photoreceptors use cGMP as an internal 
m essenger to gate cation channels and Ca2‘ ions to regulate
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synthesis of cGMP (1, 2}. In dark-adapted photoreceptors, 
cGMP-gated channels are open, cGMP phosphodiesterase is 
inhibited, and the cytoplasmic cGMP and Ca2+ concentrations 
are m aintained a t  —5 pM (3) and —300 iim (4), respectively. 
Illum ination of rhodopsin triggers an  enzymatic cascade which 
rapidly hydrolyzes cytoplasmic cGMP (5). As a consequence, 
cGMP-gated cation channels close, disabling the influx of Ca2* 
(and other cations) into the outer segment, while the light- 
insensitive NaVK*, Ca3* exchangers continue to extrude Ca2*-. 
The drop in  cytoplasmic Ca2* is the signal for a  photoreceptor 
guanylate cyclase (GC)1 (6, 7) to accelerate the rate of cGMP 
synthesis, which ultim ately enables the cell to return  to the 
dark  state. In cone photoreceptors, cytoplasmic Ca3* regulates 
a  cone GC with features indistinguishable from those in 
rods (8),
GC activation is mediated by a membrane-associated Ca**- 
binding protein which is distinct from recoverin (9-11). The 
Ca2+ dependence of GC activation is cooperative with a Hill 
coefficient of 2 -4  (9, 12, 13), indicating the presence of several 
Ca2'  binding sites in the GC activator. A Ca^-binding protein 
term ed guanylate cyclase-activating protein (GCAP) has been 
biochemically isolated from bovine retinas, shown to activate 
GC in low Ca2*, and to promote channel reopening when dia- 
lyzed into in tact gecko rods (14). A second, less well character­
ized Ca2+-bindmg protein term ed p24, possibly closely related 
to GCAP, has been postulated to also activate GC in low Ca2*
(15). In a previous report, we showed th a t a monoclonal an ti­
body raised against bacterially expressed bovine GCAP blocks 
activation of GC by GCAP in low Ca5* and th a t an N-terminal 
peptide derived from the bovine sequence is a potent inhibitor 
of GC activation (16). In situ  hybridization in bovine retinas 
suggested th a t GCAP mRNA is present in the inner segments 
of both rod and cone photoreceptors, but not in any other reti­
nal cell type, Tin explore the possible involvement of the human 
GCAP gene in retinal dystrophies, we determined in this study 
its gene structure, its expression pattern  in prim ate photore­
ceptor cells, and its chromosomal localization.
M A T ER IA L S AND M E TH O D S
Oligonucleotide Synthesis—Primers were synthesized using a PCR- 
MATE (Applied Biosystems, Inc. model 3911 DNA synthesizer. The oil-
1 The abbreviations used are: GC, guanylate cyclase; GCAP, guany­
late cyclase activating protein; PCR, polymerase chain reaction; RDS, 
























gomers were deprotected in 700 pi of 14 M ammonium hydroxide at 
55 °C for 8-12 h. An aliquot was treated with 1-butanol to remove 
ammonium hydroxide, and the precipitate was washed with isopropa- 
nol, lyophilized, and dissolved in 1 x TE (10 m.M Tris-HCl, pH 8.0, 
1 m\i EDTA). The oligomers were quantitated by spectrophotometry 
(1 OD»,nrl = 33 pg).
Southern Blotting—Genomic DNA from nine eucaryotic species was 
isolated similarly as described previously (17). Except for yeast and 
human, all genomic DNAs were from kidneys. Human DNA was iso­
lated from placental tissue. 8 pg of DNA exhaustively digested with 
EcoRI were loaded per lane. The size markers were Hindlll-digested A 
DNA. The probe was a 650-bp nick-translated fragment a (sec Fig. 2) 
amplified with primers W231 (5-GCC TGA GCG ATG GGG AAC ATT) 
and W224 (5 -GTA CAG AAA GAG TAG GCA GT) on a bovine cDNA 
template. Fragment a contains the translation start codon ATG (bold­
face), and W224 is located 10 bp downstream of the translation stop 
codon TGA. The hybridization conditions were 5 x SSPE, 10 x Den- 
hardt’s solution, 100 pg/ml denatured, sheared salmon sperm DNA, 2% 
SDS, overnight at 65-68 "C. The washing conditions were 2 x SSC 
(standard saline citrate), 0.1% SDS at room temperature, and 0.2 x 
SSC, 0.1% SDS at 65 CC, respectively, for 30 min each.
Library Screening and Characterization ofGCAPcDNA Clones—The 
isolation of two bovine GCAP cDNA clones was described previously
(16). The nick-translated fragment a was used to screen adult human 
retina AgtlO (J. Nathans, Johns Hopkins School of Medicine), and wild- 
type mouse retina AZapII (18) cDNA libraries under relaxed stringency 
(19). Of several positive clones identified in the primary screen, the 
following clones were fully characterized (see Fig. 2): two human A-gtlO 
GCAP clones (HRG3, HRG7) containing the full coding sequence of 
GCAP, two truncated Azap mouse clones (MRG1, MRG2), and one full- 
length clone (MRG4). The human AHRG3 insert was amplified with 
AgtlO primers flanking the EcoRI cloning site and subcloned into the 
PCRII vector to yield HRG3. The inserts of mouse Azap clones were
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Fig. 1. Genomic blot of various species. EcoRI-digested genomic 
DNA from nine eucaryotic species (human; monkey (rhesus); rat 
(Sprague-Dawley); mouse (BALB/c); dog; bovine; rabbit; chicken; yeast 
(S. cerevisiae)) was probed with nick-translated bovine GCAP fragment 
a (Fig. 2A) under high stringency). The size markers (indicated on the 
left) are //in d III -digested A DNA.
excised in vitro, according to the Stratagene protocol, and subcloned 
into pBluescript. The coding portions of all clones were completely 
sequenced on both strands, and PCR was performed as described 
previously (20).
DNA Sequencing—Plasmid and A DNA were purified using standard 
procedures (21). Supercoiled plasmid DNA was sequenced using the 
double-stranded procedure with universal or sequence-specific primers 
as described previously (20). A DNA was directly squenced using linear 
amplification DNA sequencing with 10 pmol of end-labeled primers and 
750-1.500 ng of A DNA (fmol sequencing kit, Promega, Madison Wl).
Human Genomic Clones—A complete gene clone (AHG1) spanning all 
exons and introns was isolated from a human genomic library (AfixII, 
Stratagene, La Jolla, CA) using fragment a as a probe (see Fig. 2). A 
genomic fragment (HGTA1,1013 bp) spanning parts of exon 2, intron 2, 
exon 3, intron 3, and parts of exon 4 was produced by PCR amplification 
with primers W238 (5-GCT ACATTC. TTT CAT GGAGTAC) and W241 
(5 -GCA TCT GGT CCT TCT GGA CGC) on a human genomic DNA 
template. Using AHG1 as a template, a second genomic fragment 
(HGTA2, 4.7 kb) spanning intron a was amplified with primers W242 
(5 -TGA AGG CCT GAG CAA TGG GCAA) and W246 (5'-GCT GAG 
GCC TGC CAC GTA CTC C). A third fragment (HGTA3, 450 bp) con­
taining mostlv upstream sequence was amplified with antisensc W245 
(ACG TAC TGG CTG GCC GAC GG) and universal primer T7. All 
amplified fragments were cloned into the PCRII vector (TA cloning kit, 
Invitrogen) and partially or completely sequenced. Two EcoRI sub­
clones. HGTA2a (2.2-kb insert) and HGTA2b (2.5-kb insert), were pro­
duced from HGTA2 by cleavage with EcoRI and religation (see Fig. 5A), 
and they were partially sequenced.
In Situ Hybridization—Monkey (Xlacaca nemestrina, female) retinas 
were obtained from the Regional Primate Research Center at the Uni­
versity of Washington, supported by National Institutes of Health 
Grant RR00166. Retinas were fixed and processed with sense and 
antisense RNA probe produced by transcription of the human GCAP 
clone HRG3 (see Fig. 2) as described previously (16).
Chromosomal Localization—The chromosomal location of the hu­
man GCAP gene was identified by PCR using human-hamster somatic 
cell hybrids and controls (BIOS Laboratories, New Haven, CT) as 
templates. For amplification of a 180-bp genomic fragment of exon 1 of 
the GCAP gene, sense primer W242 (5’-TGA AGG CCT GAG CAA 
TGG GCAA) and antisense primer W245 (5 -ACG TAC TGG CTG GCC 
GAC GG) were chosen. The PCR amplification mixture contained 50 
ng of genomic DNA, 25 ng of each primer in 25 pi, and standard con­
centrations of Taq polymerase and substrate (22). The amplification 
cycles were 4 min at 94 °C; 30 times 1 min each at 60, 72, and 94 °C; 
and 10 min at 72 °C. The BIOS panel nomenclature (human chromo­
some content in parentheses) is as follows; 010 (10); 016 (16); 212 (5D, 
Y); 324 (18); 423 (3); 683 (1<30%, 5D, 12, 14,19, 21, 22); 734 (5, 9, 18); 
750 (5, 13, 14, 15, 19); 756 (5D, 6, 7, 12<30%, 13, 14, 19, 20, 21,Y); 803 
(4, 5, 8, 22.X); 811 (8, 17, 18); 852 (2); 867 (1, 5. 13, 14, 18, 19); 909 
(5D, 6, 8, 14.X); 937 (1, 5, 14, 15, 17, 21); 940 (5, 20); 1006 (4, 5, 7. 13, 
15.19,21,Y<30%); 1049 (5, 11); 1079 (3, 5); 1099 (1, 5D, 13,19. 21,22). 
“D” denotes a partial deletion, “<30%” a partial presence of the re­
spective chromosome. The two panels containing chromosome 6 are 
boldfaced.
Fluorescent in Situ Hybridization-—For subchromosomal localiza­
tion, both HRG3 and HRG-TA1 were labeled with biotin-14-dATPusing 
the BioNick labeling system (Life Technologies, Inc.). A mixture of the 
two probes was hybridized to pro-metaphase chromosomes prepared 
from peripheral blood lymphocytes (23). The probe was cither singu­
larly or cohybridized with a digoxygenin-labeled chromosome 6 centro­
mere-specific probe (D6Z1, Oncor) and detected as described previously 
(24). To determine specific band assignments, slides were first 
Q-banded, the position of the metaphase spreads were recorded, and
Flo. 2. Physical m ap of mam malian 
cDNA clones. The coding portion of GCAP 
cDNA is schematically represented as a 
black box. The Ca‘* binding domains in 
GCAP (Ca-l, -2, -3) are highlighted. Clones 
isolated from bovine <BRG17, BRG19), hu­
man (HRG3, HRG7, and mouse iMRGl, 
MRG2, MRG4) cDNA libraries are shown as 
lines. A triangle in MRG2 indicates alterna­
tive splicing of this clone (see text). Frag­


















































Cloning o f Human and Mouse GCAP 
+1
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CAAGGAC G GC TACATTGATTTCATGGAGTAC GT GG CAG GCC TCAG CTTGGTCCTC 2 5 2
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AGGGCGT C CAGAAGGACCAGATGC TCCTGGACACACTGACACGAAGC C TGGACCT 52 7
.A . ,T .  . G ........................................................................G .............C ................................. T .
E G V Q K D Q M L L D T L T R S L D I .  176
TAC CCG CAT CGTGCGCAGGCTC CAGAATGG CGAGCAAGACGAGGAGGGG------GCT 5 8 1
G . . . G .................................. A ..................... C .............A . . C . , G . . . , C A . . C ACC AGC
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. G ...................................................................... H E . A . T S
1 9 3
1 9 4  
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Fig. 3. cDNA and  deduced  am ino acid  sequence of hum an  and  mouse GCAP. Nucleotide numbering of the human (A) and mouse (m) 
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Fu;. 4. Amino ac id  sequence alignm ent of hum an  GCAP w ith  o th e r Cas,-b ind ing  pro te ins. The hum an GCAP sequence was aligned with 
hum an recoverin tHREC (9)), Drosophila rnelanogaster frequenin {DFREQ (54)), and hum an calmodulin (HCaMi (55)). Amino acids are depicted 
in single-letter symbols. L -  T « V = M; Y = F; E = D; R «  K; A = T = S are considered conservative substitutions. For best fit, several gaps were 
introduced (shown by hyphens). Conserved residues are  shown in black boxes. Residues identical in GCAP and recoverin a re  boxed and lightly 
shaded. EF hand Caa* binding domains {EFJ to EF4) are shown as dark-shaded boxes. The myristoylation site a t the  second residue in GCAP, 
recoverin, and frequenin is indicated by a vertical zig-zagged line.
their images stored. The slides were then  destained, fluorescent in situ 
hybridization analysis with the  probe m ixture was performed, and the 
position of the  fluorescent signals relative tn the Q bands were noted 
(25)- At least 20-30 m etaphases were examined per hybridization 
using a Zeiss Axiophot microscope equipped w ith a triple band pass 
filter (4,6-diamidinu-2-phenylindule, fluorescein isothiocyunate, and 
rhod amine),
RESULTS AND DISCUSSION 
GCAP Gene Homologies Revealed by Southern blotting— 
Genomic Southern blotting is a valuable tool for identifying 
homologous genes in various species. We used a 610-bp bovine 
GCAP probe covering the coding sequence (see Fig. 2 a ) to detect 
GCAP genes in  a  variety of vertebrate Species under Stringent 
hybridization and washing conditions (Fig. 1). These conditions 
allow for approximately 10% base pair mismatches (17). The 
species tested included hum an, monkey, bovine, ra t, mouse, 
dog, rabbit and chicken. Single fragm ents were detected in 
monkey (>23 kb), ra t  (6 kb), and chicken (6.5 kb) genomic DNA 
(Fig. 1). Two major fragm ents (9.4 and 3 kb) appear to harbor 
the hum an GCAP gene (Fig. 1, lane 1). In mouse, one major (3.5 
kb) and several weakly hybridizing sm aller fragm ent gener­
ated  by internal EcoRI sites (see Fig. 3) indicate th a t the mouse 
GCAP gene is contained in less than  6 kb of genomic DNA. A 
w eaker hybridization signal was also detected in the Saccha- 
romyccs 0erevisiae (yeast) (Fig. 1, lane 9). The function of a 
calcium-binding protein in yeast related to GCAP is unknown. 
The results suggest th a t the GCAP gene structure is compact.
th a t i t  is most likely present as a single copy per haploid ge­
nome, and th a t its sequence is well conserved among vertebrate 
species.
Molecular Cloning of Human and Mouse GCAPs—To eluci­
date the hum an and mouse GCAP gene structure , we first 
cloned the corresponding cDNAs. We previously identified bo­
vine GCAP cDNA clones by screening a retina library with a 
degenerate oligonucleotide designed according to tryptic pep­
tide sequences (16). TWo overlapping cDNA clones (BRG17, 
BRG19) contained a  poly(A) tail indicating complete sequences 
in the 3 -untranslated  region. Fragm ent a (Fig. 2) was used as 
a probe to isolate homologous clones from human, and mouse 
retina libraries. The num ber of positively identified GCAP 
clones in these libraries was 1-5/25,000 plaque-forming units, 
At least one clone in each species containing a contiguous cod­
ing sequence was isolated and completely sequenced. The 
translation  s ta r t  codons of the GCAP cDNA sequences are pre­
ceded by in-frame stop codons (Fig. 3), The coding sequences 
are 603 to 615 nucleotides in length and contain no internal 
repeats as is typical for calmodulin (26) and troponin C (27). 
The lengths of the hum an (H R G 3,1.35 kb) and bovine (BRG19, 
1.2 kb) cDNA clones are in agreem ent with the sizes (1.1—1.3 
kb) of mRNAs seen on N orthern blots (results not shown). The 
sizes of the hum an and bovine GCAP mRNA are consistent 
with a transcription s ta rt point located approximately 100 hp 
upstream  of the translation s ta rt codon. Comparison of the size
insertion of 10 nucleotides a t  the putative splice junction ofin tron b and exon 3 (Fig. 5 fl)o fth e  mouse gene are boxed. The two in ternal EcoRI sites 
(GAATTC) in the mouse sequence are boldfaced and boxed. The amino acid num bering s ta rts  with the first translation in itiator (if)  of the open 
reading frame As a comparison, the amino acid residues deviating in the bovine (fc) GCAP sequence (16) are also shown. The three predicted 
EF-hand motifs for Ca‘* binding (C a l, Ca2, and Ca.1) are highlighted by a black box. The invarian t cysteines are  shown by a shaded box. The 
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Fi<;. 5. H u m a n  GCAP  g e n e  s tru c tu re .  A, graphical representation of the gene and genomic clones. Exons 1—4 of the  GCAP gene are  depicted 
as boxes, the  coding portions are filled. Introns ’ a -c . iind flanking sequences a re  shown as lines, The extent of genomic subclones HGTA1-3 is shown 
by lines ending in delimiters. HGTA2 was further subcloned into HGTA2a and HGTA2b. The multiple cloning site of the AfixII vector flanking the 
genomic in sert is hatched, and the unique restriction sites appropriate for excision of the  insert are shown. Note th a t  intron a has an internal Not I 
site. The two genomic EooRI fragm ents identified in Fig. 1 {lane 1) are shown by broken lines. The approximate position of introns relative to the 
Ca?* binding domains in GCAP cl)NA ja indicated a t  the  bottom. B, gene sequence. Exons are  shown in upper case letters, in trons in louier ease 
letters, The 4.5-kb intron a sequence is shown only partially, introns b and c are complete. The polyadenylation site AATAAA (56) and the 
transla tion  s ta r t codon ATG are boxed The nucleotide num bering s ta rts  with A of ATG: only exon sequences a re  counted. Relevant primers used 
for amplification and/or sequencing are  marked hy arrows, with the sense or antisense strand indicated bjr arrowheads. The last residue of the 
GCAP gene sequence is the site of poly(A) attachm ent. The deduced GCAP amino acid sequence is shown as single-letter symbols. Ca1’ binding sites 
are shaded.
of the mouse GCAP mRNA and the length of the  three mouse 
GCAP clones (MRG1, MRG2, MRG4) indicates truncation a t 
the 3' end of a t least 600 bp. The truncated  clone MRG2 has an 
insertion of 10 bp a t the splice junction of the last intron (Pigs. 
2 and 3) causing a  reading frameshifl. The resulting a lte rn a­
tively spliced version of mouse GCAP, if produced, would be 
truncated  due to  the presence of a stop codon three residues 
after the junction. The presence of an a lternate  splice site 10 bp 
downstream of the intron b/exon 3 junction of the mouse GCAP 
gene was verified by gene sequencing (not shown). The signifi­
cance of alternative splicing of the mouse GCAP gene is not 
known.
GCAP Is a Highly Conserved Protein—As shown in Fig. 3, the 
predicted GCAP amino acid sequences consist of 201 (human), 
202 (mouse), and 205 (bovine) residues. The sequence sim ilar­
ity among m am m alian GCAPs is better than  90% a t  the amino 
acid level The calculated molecular m asses are 21-23 kDa. 
Amino acid and sequence analysis (hydropathy plot, results not 
shown) predicts th a t vertebrate GCAPs are soluble, acidic pro­
teins (pK^ ~  4.2) lacking hydrophobic domains. Native GCAP, 
however, is membrane associated and hydrophobic, indicating 
th a t presumably other structural elem ents contribute to 
GCAP's insolubility. One such feature is N-term inal heteroge­
neous acylation (16) a t position 2 (Gly), a posttranslational 
modification which is a t least in p a rt responsible for m embrane 
association of other proteins (28-30). O ther features may in ­
clude thioacylation (possible palmitoylation of a Cys in the 
N-term inal domain {position 18, Fig. 4), or clusters of a lte rn a t­
ing positive charges capable of in teracting with negatively
charged phospholipid head groups (30). Interestingly, such a 
cluster is present in GCAP a t  position 85-97 (between EF2 and 
EF3, Fig. 4), but not in recover)n which is more soluble than  
GCAP.
Residues 1-180 of the bovine, mouse and hum an GCAF se­
quences are unusually well conserved showing only 1 or 2 non­
conservative amino acid substitutions. The N-terminal domain 
(residues 2-57, shaded in Fig. 3) is thought to be involved in GC 
activation (16). Sequence inspection reveals the presence of two 
invariant cysteines (boxed in Fig. 3) presumably indispensable 
for secondary structure, and predicts th ree EF hand structures 
involved in Ca=+ binding (a fourth domain is most likely dis­
abled, see next paragraph), The only divergent domain contain­
ing insertions/deletions is located a t the C term inus. I t consists 
of approximately 20 residues, and accounts for the variation in 
length of the hum an, mouse and bovine GCAPs.
The GCAP Sequence Is Homologous to Other Ca^-binding 
Proteins—GCAP is a novel member of the large and diverse 
superfamily of Ca2* binding proteins which includes the ubiq­
uitous and promiscuous calmodulin, frequenin (found in Dro­
sophila synapses), visinio (chicken retina), recoverin (verte­
brate photoreceptors), and over 100 others (31). Sequence 
alignm ent (Fig. 4) with recoverin (HREC), frequenin (DFREQ), 
and calmodulin (HCaM l) which derive from a common ances­
tor with four EF hand Ca2‘ binding consensus sequences shows 
31 identically conserved amino acid residues, most of them 
grouped around the four EF hand structures. The most pro­
nounced differences occur in the variahle C term ini which 
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W261 C G C CA T TAAC C C CTG CAG C GAT AC CA C CAT GACTG CAGAQGjtGT T CA C CGAT A CAGT G TT
exon 3  a i n p c s d t t m t a e e f t d t v f
W262 CTCCAASAy  GACGTCAACGGGGATGqtn«gaaaaccoaai»agaaeteeeeaoegaafla
ggtcaccatggatgtggggtcaccaggggtggaaggtcactaaaggagagggtgaggaag 
ggaggagaggcccaaaggcccccgtgctggtcacttcctccacctgcctctgccccagcc 
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12 2 5
as noted for recoverin and calmodulin (32), the length of the 
Linker between EF2 and EF3 is variable. The sequence simi­
larity between the two photoreceptor Ca2+-binding proteins re­
coverin and GCAP is only 36% even when conservative substi­
tutions are taken into account. In recoverin, cry at a llographs 
data show the presence of four EF hand  (helix-loop-helix) struc­
tures, b u t only two functional Ca2* binding sites (EF2 and EF3) 
(32). In GCAP and frequenin, the th ree domains EF2, EF3, and 
EF4 are well conserved, while insertion of a Cys and th e  pres­
ence of a rigid Pro render the first domain (EF1) incompatible 
w ith Ca2’' binding. It is interesting to note th a t secondary struc­
tu re  predictions indicate the presence of a  Greek key motif 
around the non-functional EF1 domain of GCAP (Fig. 3). Greek 
key motifs, common in the crystallins (components of the ver­
tebrate lens) and protein S (a procaryotic calcium-binding pro­
tein lacking EF hand motifs) (33, 34), contain antiparallel 
/3-strand structures. This suggests th a t the symmetric helix- 
loop-helix configuration (EF1, EF2, and EF3, EF4 separated by 
a groove) characteristic for recoverin te rtiary  structure may not 
be present in GCAP.
Human GCAP Gene Structure—Tb determ ine the intron/ 
exon distribution of the GCAP gene, th ree overlapping 
genomic clones encoding GCAP (AHG1, AHG2, AHG3) were 
isolated by screening 500,000 plaque-forming un its  of a com­
mercial AfixII genomic library. AHG1 containing all exons and 
introns of the GCAP gene as well as flanking regions was fur­
th e r characterized (Fig. 5A), Southern blotting of iVo/I-di- 
gested AHG1 revealed the presence of two fragm ents, 5 and 9 
kb in length, predicting a  14-kb insert and the presence of an
internal Notl site in the GCAP gene (Fig. 5, A and B >. A con­
tiguous physical m ap was produced by analysis of overlapping 
genomic subclones (HGTA1—3, Fig. 5A) representing various 
portions of the hum an GCAP gene. The gene structure was 
elucidated by complete sequencing of the resulting subcloned 
fragm ents and determ ination of the intron/exon splice junc­
tions (Fig. 5B).
The results show th a t the gene is split into four exons dis­
tributed over 6 kb of genomic DNA. Intron a  is 4.5 kb in length 
and contains the unique internal iTcoRI site responsible for the 
two large genomic fragm ents seen in the genomic Southern blot 
(Fig. 1, lane 1 ). The lengths of introns b and c are 370 and 347 
bp, and the two central exons are 14G and 94 bp each. The six 
splice junctions conform to the donor/acceptor consensus se­
quences (35), The positions of in trons in the GCAP gene do not 
conform to the known domain structure of GCAP. The first EF 
hand Ca2t binding domain is split by intron a, the second is 
entirely encoded by exon 2, and the third Ca2+ binding site is 
again split into two halves by intron c. In mouse, prelim inary 
results indicate th a t the intron positions are exactly as in the 
hum an gene. There is no conservation of intron/exon bound­
aries between the GCAP gene and the hum an recoverin gene 
containing three exons (36) or the hum an calmodulin gene 
CaMI containing six exons (37).
Expression of GCAP mRNA in Primate Retinas—In situ hy­
bridization with digoxygenin-labeled antisense and sense RNA 
was used to identify the retinal cell type which expresses the 
GCAP gene. As shown in Fig. 6A, no hybridization was ob­
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Fk;. 6. In  situ  hybrid ization  of GCAP RNA to m onkey re tin a  sections. Monkey retina sections were hybridized with digoxvgenin-labeled 
sense (A ► and antisense tB  I human GCAP RNA. The retina layers are indicated as follows. OS, outer segments; IS, inner segments; ONL, outer 
nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer.
toreceptor layer was selectively stained with the antisense 
probe (Fig. 6B). The most intense staining was found in the 
myoid region of cone inner segments where protein synthesis 
takes place. No other cell type of the retina appears to express 
GCAP at comparable levels. These results indicate th a t GCAP 
is expressed specifically and discretely within photoreceptors 
cells, and th a t the distribution GCAP mRNA is very sim ilar in 
prim ate and bovine retinas.
Chromosomal Localization—Tb identify the chromosome 
which contains the human GCAP gene (locus designation 
GCAP1), we performed PCR analysis on DNAs from 20 hu- 
m an-ham ster somatic cell hybrids. We selected two primers 
• W242 and W246, Fig. 5B) which amplify a 180 bp human- 
specific intron-less portion of exon 1. Only hybrids 756 and 
909 (see “M aterials and Methods”) yielded the expected prod­
uct consistent with the GCAP gene residing on chromosome 6. 
Sublocalization to the short arm  of chromosome 6 was un­
equivocally determined on banded m etaphase spreads (Fig. 7, 
A-D). Assignment of the GCAP1 locus to region 6p21.1 was 
confirmed by co-hybridization of a  chromosome 6 centromere- 
specific probe (Fig. 7jB). Consistent signals were not observed 
on any other chromosomes. Analysis of interphase cells also 
showed only one copy of the probe present in the human ge­
nome consistent with the results of genomic Southern blotting 
(Fig. 1). The position 6p21.1 is almost identical to the position 
of another photoreceptor-specific protein involved in rod disc 
structure, “retinal degeneration slow" or RDS, on 6p21.1-cen. 
Defects in the RDS gene are responsible for the rds phenotype 
in mouse (38) and have been linked to retinitis pigmentosa 
(39, 40) and m acular degenerations (41) in human. By synteny 
with RDS (42) and other loci near p21.1 (pim l oncogene.
PI M l; tum or necrosis factor, TNFA; cytochrome P450, CYP'21) 
(43), the mouse gcapl locus is predicted to reside on chromo­
some 17.
The GCAP Gene Is a Candidate for Causing Retinal 
Disorders—Defects in genes expressed in photoreceptors have 
been linked to several retinal disorders and dystrophies in ani­
mal (20, 44l and human models (45, 46). Prominent among the 
human disorders are autosomal retinitis pigmentosa (rhodop- 
sin, RDS/peripherin, phosphodiesterase-0) (45), retinitis punc­
ta ta  albescence (RDS) (47), tritanopia (blue cone opsin I (48), 
color blindness (red and green pigments) (49), m acular degen­
eration (RDS) (41), and congenital stationary night blindness 
(rhodopsin, phosphodiesterase-0) (50,51). Recently, a  new locus 
for autosomal recessive retinitis pigmentosa, distinct from 
RDS, has been identified on 6p (52), and initial mapping stud­
ies indicate th a t th is locus is within 2 cM of the GCAP gene and 
may be identical with the GCAP locus.- Since GCAP plays a key 
role in return  of the photoreceptor to the dark sta te  after illu­
mination, a defect in the GCAP gene may disturb activation of 
cyclase and possibly disable accelerated cGMP synthesis essen­
tial for depolarization of photoreceptors. A predicted phenotype 
for a GCAP missense m utation may be non-progressive night 
blindness in which cGMP levels in dark adapted photoreceptors 
are abnormally low, as has been observed in families with de­
fects in the rhodopsin gene causing constitutive activation of 
transducin (53) or in a large Danish pedigree in which a defect 
in the phosphodiesterase-0 gene causes persistent hydrolysis of 
cGMP (51). More severe phenotypes like RP and m acular de-










































Fir.. 7. Subchroraosom al localization by fluorescent in situ  hybrid ization . A, GCAP localization to chromosomc 6 on prnpidium iodide 
stained metaphase spread. The arrow points to the GCAP1 locus, li, chromosome 6 co-hybridized with human GCAP DNA Ishort arrow) and 
FITC-labeled centromeric probe D6Z1 (long arrow). C, portion of a prehybridized, Q-banded metaphase chromosome spread. The arrow indicates 
the site of hybridization at the p2I.l band of chromosme 6. D, same metaphase as in C, now stained with propidium iodide and hybridized with 























generation in  which photoreceptors progressively degenerate 
would he consistent w ith a null allele and loss of GCAP 
function.
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